Logo image
Sign in
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
Journal article   Open access   Peer reviewed

Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial

Dave Singh, Christopher Brightling, Klaus Rabe, Meilan Han, Stephanie Christenson, M Bradley Drummond, Alberto Papi, Ian Pavord, Nestor Molfino, Gun Almqvist, …
The Lancet Respiratory Medicine
12/2024
url
Find in HALView

Details

Logo image